Nebulized Ethanol for Internal Disinfecting and Improvement
Methods of the present disclosure utilize alcohol (e.g., ethanol) as an active ingredient or agent for disinfecting, washing, and/or treating infection in the upper and/or lower airways. Methods include aerosol inhalation, lung spraying, and/or lung lavage using ethanol-containing solutions. Such methods can be applied to complicated pneumonia and respiratory pandemics, including the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Europäisches Patentamt - (2020) vom: 27. Aug. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
RUBIN DARREN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-08-27, Last update posted on www.tib.eu: 2022-06-23, Last updated: 2023-02-09 |
---|
Patentnummer: |
US2020268656 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA006269303 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA006269303 | ||
003 | DE-627 | ||
005 | 20230504062246.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA006269303 | ||
035 | |a (EPA)US2020268656 | ||
035 | |a (EPA)72142592 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a RUBIN DARREN |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nebulized Ethanol for Internal Disinfecting and Improvement |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2020-08-27, Last update posted on www.tib.eu: 2022-06-23, Last updated: 2023-02-09 | ||
520 | |a Methods of the present disclosure utilize alcohol (e.g., ethanol) as an active ingredient or agent for disinfecting, washing, and/or treating infection in the upper and/or lower airways. Methods include aerosol inhalation, lung spraying, and/or lung lavage using ethanol-containing solutions. Such methods can be applied to complicated pneumonia and respiratory pandemics, including the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). | ||
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a RUBIN HOWARD |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 27. Aug. |
773 | 1 | 8 | |g year:2020 |g day:27 |g month:08 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72142592/publication/US2020268656A1?q=US2020268656 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2020 |b 27 |c 08 |
951 | |a AR | ||
952 | |j 2020 |b 27 |c 08 |